会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 127. 发明申请
    • ELECTROLYZER APPARATUS AND METHOD FOR HYDROGEN PRODUCTION
    • 电解液装置和氢生产方法
    • WO2004076721A3
    • 2004-10-28
    • PCT/US2004005182
    • 2004-02-19
    • AVALENCE LLCSHIMKO MARTIN AVERMA SANDEEPJACKSON THOMASKAMLANI JERAM S
    • SHIMKO MARTIN AVERMA SANDEEPJACKSON THOMASKAMLANI JERAM S
    • C25B1/10C25B9/08C25B9/18C25B9/00C25C1/02
    • C25B1/12C02F2201/003C25B1/10C25B9/08C25B9/18Y02E60/366
    • An electrolyzer cell (10) for the electrolysis of water comprises a cathode (12) of generally tubular configuration within which is disposed an anode (16) separated from the cathode (12) by a separation membrane (14) of generally tubular configuration which divides the electrolyte chamber (15) into an anode sub-chamber (15a) and a cathode sub-chamber (15b). An electrolyzer apparatus (36) includes an array (38) of individual cells (10) across each of which an electric potential is imposed by a DC generator (40) via electrical leads (42a, 42b). Hydrogen gas generated within cells (10) from electrolyte (18) is removed via hydrogen gas take-off lines (20) and hydrogen manifold line (21). By-product oxygen is removed from cells (10) by oxygen gas take-off lines (22) and oxygen manifold line (23). The electrolyzer apparatus (36) may be configured to operate either batchwise or in a continuous electrolyterecycle operation to produce high purity hydrogen at high pressure, e.g., up to about 10,000 psig, without need for gas compressors to compress product hydrogen.
    • 用于电解水的电解池单元(10)包括大体管状结构的阴极(12),在该阳极(12)内设置有通过大致管状构造的分离膜(14)与阴极(12)分离的阳极(16) 所述电解质室(15)进入阳极子室(15a)和阴极子室(15b)。 电解装置(36)包括单个电池(10)的阵列(38),每个电池单元(10)的每个电极通过电引线(42a,42b)由直流发电机(40)施加。 通过氢气输出管线(20)和氢气歧管管线(21)除去在电解质(18)内的电池(10)内产生的氢气。 通过氧气输出管线(22)和氧气歧管管线(23)从细胞(10)中除去副产物氧。 电解装置(36)可以配置成间歇式或连续电解循环操作,以在高压(例如高达约10,000psig)下产生高纯度氢,而不需要气体压缩机来压缩产物氢。
    • 129. 发明申请
    • FREE LIGAND ASSAY
    • 免费配对测定
    • WO1985000226A1
    • 1985-01-17
    • PCT/GB1984000220
    • 1984-06-22
    • EKINS, Roger, PhilipJACKSON, Thomas, Michael
    • G01N33/53
    • G01N33/78G01N33/53Y10S436/804Y10S436/817
    • A method of measuring the concentration of a free ligand in a biological fluid containing the free ligand and ligand bound to endogenous binding agent, comprises; a) mixing a sample of the fluid with an analogue of the ligand, a specific binder with which the free ligand and the ligand analogue bind, and an exogenous binding agent which binds the ligand analogue but not the ligand, either the ligand analogue or the specific binder being labelled; b) incubating the resulting mixture so that the ligand and ligand analogue compete for the specific binder; c) determining either the amount of the labelled analogue bound to the specific binder or the exogenous binding agent or the amount of labelled specific binder bound, or not bound, to the ligand analogue; and d) correlating the determined amount to the amount of free ligand present in the sample. The method is especially usefull where the ligand analogue binds with endogenous binding agent and the extent of binding varies from sample to sample of the biological fluid. It may be used to measure concentration of free thyroid hormones and other hormones in body fluids, employing antibodies specific to the ligand analogue as the exogenous binding agents.